NuraLogix Launches 20-Year Cardiovascular Risk Index to Advance Predictive Heart Health Monitoring
Toronto, ON — NuraLogix, a company developing contactless health insight technology, has introduced a new multi-year cardiovascular disease (CVD) risk model capable of estimating an individual’s long-term likelihood of developing cardiovascular disease over timeframes ranging from one to twenty years.
The model builds upon NuraLogix’s existing 10-year cardiovascular prediction tool, expanding its predictive reach and flexibility for use by health technology partners, wellness platforms, and research organizations. The goal is to provide more comprehensive insights into population-level heart health trajectories and the potential long-term effects of lifestyle and wellness interventions — all through a camera-based, contactless approach.
Expanding Predictive Horizons in Heart Health
Cardiovascular disease remains the leading cause of death worldwide, responsible for nearly 18 million deaths annually, according to the World Health Organization (WHO). Over 80% of these fatalities result from heart attacks and strokes, with roughly one-third occurring prematurely in individuals under age 70.
While much of healthcare focuses on treatment, early detection and continuous risk awareness are key to prevention. NuraLogix’s new model is designed to support that shift by offering long-range insights into cardiovascular risk progression.
“Cardiovascular disease doesn’t develop overnight,” said Dr. Keith Thompson, Chief Medical Officer at NuraLogix. “By extending our predictive horizon to 20 years, this capability provides valuable insight into how lifestyle and wellness factors could influence long-term cardiovascular health. It empowers users and organizations to make data-informed decisions that support prevention and early intervention.”
A More Representative and Adaptive Model
The new cardiovascular risk model was trained using data from more than 100,000 individuals across diverse populations, creating a globally representative dataset that goes beyond earlier U.S.-centric versions.
Unlike traditional regression-based risk calculators, NuraLogix’s model employs advanced machine-learning techniques that can adapt to complex physiological patterns across regions and demographics. The company says this adaptive design enhances accuracy and relevance for broader use in both clinical and consumer health settings.
Enabling Proactive, Contactless Health Insights
NuraLogix’s technology powers the Anura® platform, which uses standard video cameras to analyze facial blood flow patterns and estimate various health metrics. The new long-term cardiovascular outlook extends the platform’s potential for preventive health applications by allowing users to visualize and monitor their estimated cardiovascular risk over multiple time horizons.
The company says this multi-year model represents a step forward in its mission to make preventive health insights more accessible through non-invasive, AI-driven technologies.
